Belite Bio Chief Medical Officer Hendrik Peter Scholl reports ADS disposal valued at $80,048.70
Belite Bio Chief Medical Officer Hendrik Peter Scholl reported selling 500 American depositary shares on Oct. 1. Sales prices ranged from USD 163.625 to USD 170.02 per share. * Indirect holding via Bioptima Ltd. fell to 14,500 American depositary shares. Transactions were executed under a Rule 10b5-1 trading plan adopt